ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.

Quote:

Search for Ticker

Free Membership

Search:

MRGE: Merge Healthcare Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

MERGE HEALTHCARE INC (NASD)
MRGE	3.11	N/A	(N/A%)	Vol. 0	N/A ET

MERGE HEALTHCARE is a developer of medical imaging and clinical software applications and developmental tools that are on the forefront of medicine. The Company develops medical imaging software solutions that support end-to-end business and clinical workflow for radiology department and specialty practices, imaging centers and hospitals. Their software technologies accelerate market delivery for their OEM customers, while their end-user solutions improve their customers' productivity and enhance the quality of the patient experience.

General Information

MERGE HEALTHCAR

6737 West Washington Street Suite 2250 Milwaukee, OH 53214-5650 Phone: 414-977-4000 Fax: 414-977-4200 Web: www.merge.com Email: ir@mergehealthcare.com

Industry	MEDICAL INFO SYS
Sector:	Medical

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	02/11/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	3.11
52 Week High	4.78
52 Week Low	0.26
Beta	0.87
20 Day Moving Average	271,579.19
Target Price Consensus	4.5

% Price Change
4 Week	-19.42
12 Week	-12.78
YTD	139.84

% Price Change Relative to S&P 500
4 Week	-20.29
12 Week	-17.77
YTD	98.50

Share Information
Shares Outstanding (millions)	60.13
Market Capitalization (millions)	184.60
Short Ratio	5.87
Last Split Date	N/A

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	0.03
Current Year EPS Consensus Estimate	0.17
Estimated Long-Term EPS Growth Rate	20.00
Next EPS Report Date	02/11/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	3.00
30 Days Ago	2.00
60 Days Ago	2.00
90 Days Ago	2.00

Fundamental Ratios

P/E
Current FY Estimate:	18.06
Trailing 12 Months:	30.70
PEG Ratio	0.90

EPS Growth
vs. Previous Year	0.00%
vs. Previous Quarter	0.00%

Sales Growth
vs. Previous Year	15.67%
vs. Previous Quarter:	10.12%

Price Ratios
Price/Book	4.14
Price/Cash Flow	-
Price / Sales	2.95

ROE
09/30/09	32.79
06/30/09	57.62
03/31/09	-36.05

ROA
09/30/09	9.99
06/30/09	10.80
03/31/09	-5.45

Current Ratio
09/30/09	0.91
06/30/09	1.06
03/31/09	1.58

Quick Ratio
09/30/09	0.90
06/30/09	1.05
03/31/09	1.57

Operating Margin
09/30/09	10.26
06/30/09	9.71
03/31/09	-5.30

Net Margin
09/30/09	7.03
06/30/09	9.93
03/31/09	-22.38

Pre-Tax Margin
09/30/09	7.03
06/30/09	9.93
03/31/09	-22.38

Book Value
09/30/09	0.74
06/30/09	0.23
03/31/09	0.22

Inventory Turnover
09/30/09	58.45
06/30/09	39.47
03/31/09	27.68

Debt-to-Equity
09/30/09	0.00
06/30/09	0.00
03/31/09	1.19

Debt to Capital
09/30/09	0.20
06/30/09	0.00
03/31/09	54.33


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research